Participation is free and no prerequisites are required
All previous recordings can be accessed at the ISV YouTube Channel
2025 ISV Mini-Symposia
ISV Mini-Symposium on HIV Vaccines
TITLE: Clinical Progress Toward Vaccine Induction of HIV Broadly Neutralizing Antibodies, William Schief, Moderna
TITLE: Immune Correlates of Protection for HIV Vaccines; Peter Gilbert, Fred Hutch Cancer Center
TITLE:The Progress of Polyvalent DNA Prime and Protein Boost HIV Vaccine (PDPHV); Shan Lu, UMASS Chan Medical School and Worcester HIV Vaccine (WHV)
Conference Chairs
Lindsey Baden, BWH, Harvard
Nyaradzo Mgodi, University of Zimbabwe Clinical Trials Research Centre
ISV Mini-Symposium on RSV Vaccines
TITLE: Global Lifelong Burden of RSV; Louis Bont, M.D., Ph.D, Professor, University Medical Center Utrecht
TITLE: Prefusion-F Stability and Vaccine Efficacy: Structure-Based Vaccines for RSV/HMPV/PIV; Peter Kwong, Ph.D, Richard J. Stock Professor, Biochemistry and Molecular Biophysics Columbia University
TITLE: PIV5-vectored RSV Intranasal Vaccine (BLB201) is Safe and Immunogenic in Healthy Adults and Young Children; Hong Jin, Ph.D, Chief Scientific Officer, CynVac/Blue Lake Bio
TITLE: RSVPreF Vaccine in Older Adults and At-Risk Adults Aged 18 – 59 Years; Kumar Ilangovan, MD, MSPH, MMCi, FACP, FAAP, Director, Vaccines Clinical Research & Global Clinical Lead, RSV Adult Vaccine Program, Pfizer Vaccine
Introduction:
Nnenna Chime, MD, AVP and Head Global Clinical Franchise, Vaccines R&D, Sanofi
ISV Mini-Symposium on Pneumococcal Vaccines
TITLE: Impact of Vaccines on Pneumococcal Disease; Kathleen McElwee, Pfizer
TITLE: Real live impact data following switch of vaccines; Stefanie Desmet, UZ Leuve
TITLE: Regulatory considerations for novel serotype independent pneumococcal vaccines; Norman Baylor, Sabin Vaccine Institute
TITLE: Overview of the International Society of Pneumonia and Pneumococcal Diseases and its activities; Cynthia Whitney, Cynthia Whitney
